Transcriptional Intermediary Factor 1γ–Induced Irisin in Skeletal Muscle Attenuates Renal Fibrosis in Diabetic Nephropathy
ABSTRACT Background Transcriptional intermediary factor 1γ (TIF1γ) is a negative regulator of TGF‐β1 signalling and has been associated with patient survival in renal cell carcinoma. However, its role in diabetes mellitus (DM), particularly in diabetic nephropathy (DN), remains unclear. DN is the le...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-04-01
|
| Series: | Journal of Cachexia, Sarcopenia and Muscle |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/jcsm.13810 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849724456497315840 |
|---|---|
| author | Jin Hyun Kim Seunghye Lee Hani Jang Sehyun Jung Myeong Hee Jung Jeong Won Yun Haejin Jeon Hyun‐Jung Kim Se‐Ho Chang Eun Ju Lee Hyo‐Soo Kim |
| author_facet | Jin Hyun Kim Seunghye Lee Hani Jang Sehyun Jung Myeong Hee Jung Jeong Won Yun Haejin Jeon Hyun‐Jung Kim Se‐Ho Chang Eun Ju Lee Hyo‐Soo Kim |
| author_sort | Jin Hyun Kim |
| collection | DOAJ |
| description | ABSTRACT Background Transcriptional intermediary factor 1γ (TIF1γ) is a negative regulator of TGF‐β1 signalling and has been associated with patient survival in renal cell carcinoma. However, its role in diabetes mellitus (DM), particularly in diabetic nephropathy (DN), remains unclear. DN is the leading cause of chronic kidney disease (CKD). We investigated the potential role of TIF1γ in mitigating multiple DM‐related complications. Methods Mice were divided into four groups: db/m+, db/db and db/db mice treated with cytomegalovirus‐ or TGF‐TIF1γ plasmids (40 μg/mouse; intraperitoneally weekly for 16 weeks). Renal injury, fibrosis, function and gene expression related to fibrosis and epithelial–mesenchymal transition (EMT) in the kidneys were assessed. Muscle atrophy, regeneration markers, myokine levels and exercise capacity were evaluated. C2C12 cells were exposed to palmitate with or without TIF1γ transfection, and irisin expression and secretion were measured. Muscle‐kidney crosstalk was analysed using conditioned media (CM) from TIF1γ‐transfected C2C12 cells in palmitate‐treated human kidney (HK)‐2 cells. Additionally, HK‐2 cells were incubated in CM from fibronectin type III domain‐containing protein (FNDC)5‐knockdown C2C12 cells to confirm irisin‐mediated kidney crosstalk by TIF1γ. Results TIF1γ treatment in db/db mice resulted in a significant attenuation of renal tubulointerstitial fibrosis (1.5‐fold decrease), glomerular injury (1.8‐fold improvement), tubular injury (1.6‐fold improvement), renal dysfunction (1.7‐fold improvement) and a reduction in EMT‐related factors (1.8‐fold decrease) (p < 0.05). The levels of administered TIF1γ plasmids were higher in skeletal muscle than in renal tissues. TIF1γ expression was significantly elevated in the skeletal muscle of db/db mice treated with TIF1γ plasmids (6.5‐fold) (p < 0.05). Mice receiving both plasmids exhibited a 1.8‐fold reduction in pathological muscle morphology and atrophy‐related gene expression, a 3.0‐fold increase in regeneration‐related gene expression and a 1.6‐fold improvement in muscle function (p < 0.05). Irisin expression increased by 2.1‐fold in skeletal muscle and serum (p < 0.05). In TIF1γ‐transfected C2C12 cells, irisin secretion was elevated by 1.5‐fold (p < 0.05). CM from TIF1γ‐transfected C2C12 cells attenuated EMT in palmitate‐treated HK‐2 cells, compared with medium from nontransfected C2C12 cells (1.9‐fold improvement [p < 0.05]). Conversely, FNDC5 knockdown in C2C12 cells accelerated EMT in palmitate‐treated HK‐2 cells, as evidenced by decreased bone morphogenetic protein‐7 (1.6‐fold) and increased EMT‐related factors (2.1‐fold) (p < 0.05), compared with palmitate alone and small interfering RNA control. Conclusions Our findings emphasize the potential of TIF1γ as a multitargeted therapeutic agent for DN, mitigating both renal and muscular complications through direct fibrosis inhibition and indirect myokine‐mediated inter‐organ crosstalk. |
| format | Article |
| id | doaj-art-eafdf74e4a9d48b8b69c7cb5a9a121cf |
| institution | DOAJ |
| issn | 2190-5991 2190-6009 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Cachexia, Sarcopenia and Muscle |
| spelling | doaj-art-eafdf74e4a9d48b8b69c7cb5a9a121cf2025-08-20T03:10:43ZengWileyJournal of Cachexia, Sarcopenia and Muscle2190-59912190-60092025-04-01162n/an/a10.1002/jcsm.13810Transcriptional Intermediary Factor 1γ–Induced Irisin in Skeletal Muscle Attenuates Renal Fibrosis in Diabetic NephropathyJin Hyun Kim0Seunghye Lee1Hani Jang2Sehyun Jung3Myeong Hee Jung4Jeong Won Yun5Haejin Jeon6Hyun‐Jung Kim7Se‐Ho Chang8Eun Ju Lee9Hyo‐Soo Kim10Biomedical Research Institute Gyeongsang National University Hospital Jinju Republic of KoreaDivision of Nephrology, Department of Internal Medicine Gyeongsang National University College of Medicine and Gyeongsang National University Hospital Jinju Republic of KoreaInstitute of Medical Science Gyeongsang National University Jinju Republic of KoreaDivision of Nephrology, Department of Internal Medicine Gyeongsang National University College of Medicine and Gyeongsang National University Hospital Jinju Republic of KoreaBiomedical Research Institute Gyeongsang National University Hospital Jinju Republic of KoreaBiomedical Research Institute Gyeongsang National University Hospital Jinju Republic of KoreaDivision of Nephrology, Department of Internal Medicine Gyeongsang National University College of Medicine and Gyeongsang National University Hospital Jinju Republic of KoreaInstitute of Medical Science Gyeongsang National University Jinju Republic of KoreaInstitute of Medical Science Gyeongsang National University Jinju Republic of KoreaBiomedical Research Institute Seoul National University Hospital Seoul Republic of KoreaMolecular Medicine & Biopharmaceutical Sciences Seoul National University Seoul Republic of KoreaABSTRACT Background Transcriptional intermediary factor 1γ (TIF1γ) is a negative regulator of TGF‐β1 signalling and has been associated with patient survival in renal cell carcinoma. However, its role in diabetes mellitus (DM), particularly in diabetic nephropathy (DN), remains unclear. DN is the leading cause of chronic kidney disease (CKD). We investigated the potential role of TIF1γ in mitigating multiple DM‐related complications. Methods Mice were divided into four groups: db/m+, db/db and db/db mice treated with cytomegalovirus‐ or TGF‐TIF1γ plasmids (40 μg/mouse; intraperitoneally weekly for 16 weeks). Renal injury, fibrosis, function and gene expression related to fibrosis and epithelial–mesenchymal transition (EMT) in the kidneys were assessed. Muscle atrophy, regeneration markers, myokine levels and exercise capacity were evaluated. C2C12 cells were exposed to palmitate with or without TIF1γ transfection, and irisin expression and secretion were measured. Muscle‐kidney crosstalk was analysed using conditioned media (CM) from TIF1γ‐transfected C2C12 cells in palmitate‐treated human kidney (HK)‐2 cells. Additionally, HK‐2 cells were incubated in CM from fibronectin type III domain‐containing protein (FNDC)5‐knockdown C2C12 cells to confirm irisin‐mediated kidney crosstalk by TIF1γ. Results TIF1γ treatment in db/db mice resulted in a significant attenuation of renal tubulointerstitial fibrosis (1.5‐fold decrease), glomerular injury (1.8‐fold improvement), tubular injury (1.6‐fold improvement), renal dysfunction (1.7‐fold improvement) and a reduction in EMT‐related factors (1.8‐fold decrease) (p < 0.05). The levels of administered TIF1γ plasmids were higher in skeletal muscle than in renal tissues. TIF1γ expression was significantly elevated in the skeletal muscle of db/db mice treated with TIF1γ plasmids (6.5‐fold) (p < 0.05). Mice receiving both plasmids exhibited a 1.8‐fold reduction in pathological muscle morphology and atrophy‐related gene expression, a 3.0‐fold increase in regeneration‐related gene expression and a 1.6‐fold improvement in muscle function (p < 0.05). Irisin expression increased by 2.1‐fold in skeletal muscle and serum (p < 0.05). In TIF1γ‐transfected C2C12 cells, irisin secretion was elevated by 1.5‐fold (p < 0.05). CM from TIF1γ‐transfected C2C12 cells attenuated EMT in palmitate‐treated HK‐2 cells, compared with medium from nontransfected C2C12 cells (1.9‐fold improvement [p < 0.05]). Conversely, FNDC5 knockdown in C2C12 cells accelerated EMT in palmitate‐treated HK‐2 cells, as evidenced by decreased bone morphogenetic protein‐7 (1.6‐fold) and increased EMT‐related factors (2.1‐fold) (p < 0.05), compared with palmitate alone and small interfering RNA control. Conclusions Our findings emphasize the potential of TIF1γ as a multitargeted therapeutic agent for DN, mitigating both renal and muscular complications through direct fibrosis inhibition and indirect myokine‐mediated inter‐organ crosstalk.https://doi.org/10.1002/jcsm.13810chronic kidney diseasediabetic nephropathyfibrosisirisinmuscle‐kidney crosstalktranscriptional intermediary factor 1γ |
| spellingShingle | Jin Hyun Kim Seunghye Lee Hani Jang Sehyun Jung Myeong Hee Jung Jeong Won Yun Haejin Jeon Hyun‐Jung Kim Se‐Ho Chang Eun Ju Lee Hyo‐Soo Kim Transcriptional Intermediary Factor 1γ–Induced Irisin in Skeletal Muscle Attenuates Renal Fibrosis in Diabetic Nephropathy Journal of Cachexia, Sarcopenia and Muscle chronic kidney disease diabetic nephropathy fibrosis irisin muscle‐kidney crosstalk transcriptional intermediary factor 1γ |
| title | Transcriptional Intermediary Factor 1γ–Induced Irisin in Skeletal Muscle Attenuates Renal Fibrosis in Diabetic Nephropathy |
| title_full | Transcriptional Intermediary Factor 1γ–Induced Irisin in Skeletal Muscle Attenuates Renal Fibrosis in Diabetic Nephropathy |
| title_fullStr | Transcriptional Intermediary Factor 1γ–Induced Irisin in Skeletal Muscle Attenuates Renal Fibrosis in Diabetic Nephropathy |
| title_full_unstemmed | Transcriptional Intermediary Factor 1γ–Induced Irisin in Skeletal Muscle Attenuates Renal Fibrosis in Diabetic Nephropathy |
| title_short | Transcriptional Intermediary Factor 1γ–Induced Irisin in Skeletal Muscle Attenuates Renal Fibrosis in Diabetic Nephropathy |
| title_sort | transcriptional intermediary factor 1γ induced irisin in skeletal muscle attenuates renal fibrosis in diabetic nephropathy |
| topic | chronic kidney disease diabetic nephropathy fibrosis irisin muscle‐kidney crosstalk transcriptional intermediary factor 1γ |
| url | https://doi.org/10.1002/jcsm.13810 |
| work_keys_str_mv | AT jinhyunkim transcriptionalintermediaryfactor1ginducedirisininskeletalmuscleattenuatesrenalfibrosisindiabeticnephropathy AT seunghyelee transcriptionalintermediaryfactor1ginducedirisininskeletalmuscleattenuatesrenalfibrosisindiabeticnephropathy AT hanijang transcriptionalintermediaryfactor1ginducedirisininskeletalmuscleattenuatesrenalfibrosisindiabeticnephropathy AT sehyunjung transcriptionalintermediaryfactor1ginducedirisininskeletalmuscleattenuatesrenalfibrosisindiabeticnephropathy AT myeongheejung transcriptionalintermediaryfactor1ginducedirisininskeletalmuscleattenuatesrenalfibrosisindiabeticnephropathy AT jeongwonyun transcriptionalintermediaryfactor1ginducedirisininskeletalmuscleattenuatesrenalfibrosisindiabeticnephropathy AT haejinjeon transcriptionalintermediaryfactor1ginducedirisininskeletalmuscleattenuatesrenalfibrosisindiabeticnephropathy AT hyunjungkim transcriptionalintermediaryfactor1ginducedirisininskeletalmuscleattenuatesrenalfibrosisindiabeticnephropathy AT sehochang transcriptionalintermediaryfactor1ginducedirisininskeletalmuscleattenuatesrenalfibrosisindiabeticnephropathy AT eunjulee transcriptionalintermediaryfactor1ginducedirisininskeletalmuscleattenuatesrenalfibrosisindiabeticnephropathy AT hyosookim transcriptionalintermediaryfactor1ginducedirisininskeletalmuscleattenuatesrenalfibrosisindiabeticnephropathy |